Ftse Mib
37.090,72
-0,08%
DAX
21.899,98
-0,06%
S&P 500
6.096,98
0,22%
NASDAQ
19.833,23
0,21%
Bitcoin
99.964,07
3,52%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biora Therapeutics Inc (BIOR) Biora Therapeutics Inc (BIOR) Notizie

BIOR

Biora Therapeutics (BIOR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIOR
DataOraFonteTitoloSimboloCompagnia
30/12/202414:00GlobeNewswire Inc.Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future GrowthNASDAQ:BIORBiora Therapeutics Inc
10/12/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
14/11/202414:00GlobeNewswire Inc.Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:BIORBiora Therapeutics Inc
07/11/202422:30GlobeNewswire Inc.Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:BIORBiora Therapeutics Inc
29/10/202413:37Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202413:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202413:00GlobeNewswire Inc.Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BIORBiora Therapeutics Inc
28/10/202413:00GlobeNewswire Inc.Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD MeetingNASDAQ:BIORBiora Therapeutics Inc
23/10/202423:24Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BIORBiora Therapeutics Inc
14/10/202414:00GlobeNewswire Inc.Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery MeetingNASDAQ:BIORBiora Therapeutics Inc
11/10/202422:52Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIORBiora Therapeutics Inc
09/10/202423:40Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BIORBiora Therapeutics Inc
07/10/202414:00GlobeNewswire Inc.Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics SymposiumNASDAQ:BIORBiora Therapeutics Inc
30/09/202414:00GlobeNewswire Inc.Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024NASDAQ:BIORBiora Therapeutics Inc
09/09/202414:00GlobeNewswire Inc.Biora Therapeutics Achieves ISO 13485 CertificationNASDAQ:BIORBiora Therapeutics Inc
04/09/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIORBiora Therapeutics Inc
28/08/202414:00GlobeNewswire Inc.Biora Therapeutics Announces Positive Nasdaq Listing DecisionNASDAQ:BIORBiora Therapeutics Inc
26/08/202414:00GlobeNewswire Inc.Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BIORBiora Therapeutics Inc
23/08/202423:13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BIORBiora Therapeutics Inc
20/08/202422:15Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BIORBiora Therapeutics Inc
16/08/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIORBiora Therapeutics Inc
12/08/202422:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIORBiora Therapeutics Inc
12/08/202422:15GlobeNewswire Inc.Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:BIORBiora Therapeutics Inc
12/08/202422:05GlobeNewswire Inc.Biora Therapeutics Announces Funding Agreement with Existing InvestorsNASDAQ:BIORBiora Therapeutics Inc
08/08/202422:30GlobeNewswire Inc.Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:BIORBiora Therapeutics Inc
06/08/202414:00GlobeNewswire Inc.Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:BIORBiora Therapeutics Inc
18/07/202414:00GlobeNewswire Inc.Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL EventNASDAQ:BIORBiora Therapeutics Inc
08/07/202414:00GlobeNewswire Inc.Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024NASDAQ:BIORBiora Therapeutics Inc
01/07/202414:00GlobeNewswire Inc.Biora Therapeutics Announces Positive Clinical Trial Results for BT-600NASDAQ:BIORBiora Therapeutics Inc
11/06/202414:00GlobeNewswire Inc.Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024NASDAQ:BIORBiora Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIOR

La tua Cronologia

BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
BPSO
Banca Popolare di Sondrio
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BAMI
Banco BPM
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
NEXI
Nexi S.p.A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci